Screening novel antiviral compounds to treat Clostridioides difficile infections
Brice J. Stolz, Ahmed A. Abouelkhair, Mohamed N. Seleem · 2024
Read Screening novel antiviral compounds to treat Clostridioides difficile infections by Brice J. Stolz, Ahmed A. Abouelkhair, Mohamed N. Seleem (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642915.txt.
Description
Brice Stolz, Ahmed Abouelkhair, and Mohamed Seleem hunt for new drugs against a gut infection in a 2024 study. The germ, Clostridioides difficile, often strikes after antibiotics upset the gut, and infections tend to come back. New treatments are badly needed. The team screened a library of antiviral drugs, on the chance that some might also kill this bacterium.
Six hundred eighteen drugs were tested, and nine held the germ back at low doses. Four stood out against fifteen strains of the germ, with strength near the standard drug vancomycin. They also spared the normal gut microbes tested. One, a plant compound from mangosteen fruit, killed the germ in under an hour. The other three stopped its growth without killing it outright. The authors present all four as leads for new therapy.
Catalog record
| CREATOR | Brice J. Stolz, Ahmed A. Abouelkhair, Mohamed N. Seleem |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |